Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


27.05.2024

1 Abdom Radiol (NY)
1 Acad Radiol
1 Acta Cytol
1 Acta Obstet Gynecol Scand
1 Asia Pac J Oncol Nurs
1 Biomarkers
1 Biomol Biomed
1 Biophys J
1 BMC Cancer
1 BMC Public Health
4 BMC Womens Health
1 BMJ Case Rep
1 Cancer Control
2 Cancer Med
1 Cell Biochem Biophys
1 Chem Biol Interact
1 Curr Issues Mol Biol
3 Curr Oncol
2 Epidemiol Prev
1 Ethiop J Health Sci
1 Eur J Contracept Reprod Health Care
1 Eur J Obstet Gynecol Reprod Biol
1 Eur J Obstet Gynecol Reprod Biol X
1 Eur Rev Med Pharmacol Sci
1 FASEB J
1 Front Genet
1 Front Med (Lausanne)
5 Front Oncol
1 Gulf J Oncolog
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Health Policy Open
1 Heliyon
2 Hum Vaccin Immunother
1 Int J Womens Health
1 J Cancer Educ
1 J Cancer Res Clin Oncol
1 J Cytol
4 J Gynecol Oncol
1 J Mol Diagn
1 J Radiat Res
1 Mar Drugs
1 Mol Cell Biochem
1 Nat Commun
1 Oncogene
2 PLoS One
1 Prev Med
1 Radiother Oncol
1 Rev Bras Ginecol Obstet
1 Rev Med Liege
1 SAGE Open Med
1 SAGE Open Med Case Rep
1 Sci Rep
1 Tohoku J Exp Med
1 Transl Oncol
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Abdom Radiol (NY)

  1. FANG Y, Wang K, Xiao M, Cheng J, et al
    Multiparametric MRI-based radiomics nomogram for identifying cervix-corpus junction cervical adenocarcinoma from endometrioid adenocarcinoma.
    Abdom Radiol (NY). 2024;49:1557-1568.
    PubMed         Abstract available


    Acad Radiol

  2. LIN Y, Gao Y, Weng T
    Construction and Validation of a MRI?Based Radiomic Nomogram to Predict Overall Survival in Patients with Local Advanced Cervical Cancer: A Multicenter Study.
    Acad Radiol. 2024 May 20:S1076-6332(24)00289-7. doi: 10.1016/j.acra.2024.
    PubMed         Abstract available


    Acta Cytol

  3. GAO Y, Zi D, Liang W, Qiu F, et al
    PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis.
    Acta Cytol. 2024;68:137-144.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  4. CASSANI C, Dominoni M, Pasquali MF, Gardella B, et al
    The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis.
    Acta Obstet Gynecol Scand. 2024;103:1028-1035.
    PubMed         Abstract available


    Asia Pac J Oncol Nurs

  5. LEE H, Mtengezo JT, Makin MS, Shi L, et al
    Mobile health-delivered narrative intervention to increase cervical cancer screening among Malawian women living with HIV: A pilot randomized controlled trial.
    Asia Pac J Oncol Nurs. 2024;11:100448.
    PubMed         Abstract available


    Biomarkers

  6. WU G, Gu M, Zhu J, Gu R, et al
    Prognostic prediction of oxidative stress related hematological biomarkers in locally advanced cervical cancer patients undergoing chemoradiotherapy.
    Biomarkers. 2024 May 20:1-28. doi: 10.1080/1354750X.2024.2358300.
    PubMed         Abstract available


    Biomol Biomed

  7. YANG H, Huang SG, Dong M, Wang X, et al
    Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients.
    Biomol Biomed. 2024 May 16. doi: 10.17305/bb.2024.10528.
    PubMed         Abstract available


    Biophys J

  8. XU G, Chai S, Zhang R, Chen M, et al
    The Contribution and Mechanism of Hypoxia /USP19/Beclin-1 Feed-Forward Loop in Cervical Cancer.
    Biophys J. 2024 May 20:S0006-3495(24)00328-X. doi: 10.1016/j.bpj.2024.
    PubMed         Abstract available


    BMC Cancer

  9. BUYUKBAYRAM ME, Hannarici Z, Turhan A, Caglar AA, et al
    A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).
    BMC Cancer. 2024;24:626.
    PubMed         Abstract available


    BMC Public Health

  10. LIU Y, Shi W, Mubarik S, Wang F, et al
    Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
    BMC Public Health. 2024;24:1349.
    PubMed         Abstract available


    BMC Womens Health

  11. KABANDA R, Kiconco A, Ronald A, Beyer KMM, et al
    Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study.
    BMC Womens Health. 2024;24:296.
    PubMed         Abstract available

  12. DONG B, Zhou SF
    Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
    BMC Womens Health. 2024;24:297.
    PubMed         Abstract available

  13. HAQUE M, Hossen MS
    Insights into pelvic insufficiency fracture following pelvic radiotherapy for cervical cancer: a comparative review.
    BMC Womens Health. 2024;24:306.
    PubMed         Abstract available

  14. CHEN JW, Huang YJ, Wang LL, Liu JJ, et al
    Mullerian adenosarcoma of the uterus with MASO: a case report of cervical adenosarcoma in a young female that never had sexual behavior.
    BMC Womens Health. 2024;24:308.
    PubMed         Abstract available


    BMJ Case Rep

  15. KUMARI S, Chandra R
    Complete double ureter in a case of carcinoma cervix: incidental intraoperative diagnosis and implications.
    BMJ Case Rep. 2023;16:e255971.
    PubMed        


    Cancer Control

  16. GAO Y, Zhang M, Zheng Y, Huang H, et al
    Human Papilloma Virus Infection and Gene Subtypes Analysis in Women Undergoing Physical Examinations: A 2015-2020 Study in Wenzhou, China.
    Cancer Control. 2024;31:10732748241257902.
    PubMed         Abstract available


    Cancer Med

  17. LIN J, Lin J, Liu L, Xie N, et al
    A novel nomogram based on inflammation biomarkers for predicting radiation cystitis in patients with local advanced cervical cancer.
    Cancer Med. 2024;13:e7245.
    PubMed         Abstract available

  18. CREAGH NS, Saunders T, Brotherton J, Hocking J, et al
    Practitioners support and intention to adopt universal access to self-collection in Australia's National Cervical Screening Program.
    Cancer Med. 2024;13:e7254.
    PubMed         Abstract available


    Cell Biochem Biophys

  19. IFTEKHARUL FERDOUS AHM, Islam MS, Noor KS, Bani MM, et al
    Harnessing THz Technology: Biosensor for Highly Accurate Cervical Cancer Cell Detection via Refractive Index.
    Cell Biochem Biophys. 2024 May 24. doi: 10.1007/s12013-024-01318.
    PubMed         Abstract available


    Chem Biol Interact

  20. LI X, Yu D, Wang Q, Chen Y, et al
    Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach.
    Chem Biol Interact. 2024;396:111058.
    PubMed         Abstract available


    Curr Issues Mol Biol

  21. HUANG Y, Wan XW, Du YT, Feng Y, et al
    Norcantharidin Enhances the Antitumor Effect of 5-Fluorouracil by Inducing Apoptosis of Cervical Cancer Cells: Network Pharmacology, Molecular Docking, and Experimental Validation.
    Curr Issues Mol Biol. 2024;46:3906-3918.
    PubMed         Abstract available


    Curr Oncol

  22. WOLF J, Wu Y, Hayek J, Zhang Q, et al
    Trends in Early-Stage Cervical Cancer Management in the US: A National Cancer Database Analysis.
    Curr Oncol. 2024;31:2836-2845.
    PubMed         Abstract available

  23. FAN KY, Chehade R, Wang AY, Sachdeva A, et al
    Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey.
    Curr Oncol. 2024;31:2610-2619.
    PubMed         Abstract available

  24. MOLNAR O, Straciuc OM, Mihutiu S, Lazar L, et al
    Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.
    Curr Oncol. 2024;31:2508-2526.
    PubMed         Abstract available


    Epidemiol Prev

  25. CHIEREGHIN A, Squillace L, Pizzi L, Sanna T, et al
    Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
    Epidemiol Prev. 2024;48:158-164.
    PubMed         Abstract available

  26. GIRARDI D, Vecchio R, Tanious M, Cacitti S, et al
    Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
    Epidemiol Prev. 2024;48:130-139.
    PubMed         Abstract available


    Ethiop J Health Sci

  27. MAKHDOOM H
    Merkel Cell Polyomavirus and their Association with the Pathogenesis of Cervical Squamous Cell Carcinomas and Adenocarcinomas: A Review Article.
    Ethiop J Health Sci. 2023;33:711-720.
    PubMed         Abstract available


    Eur J Contracept Reprod Health Care

  28. JANS L, Brynhildsen J, Cherif E, Tenerz L, et al
    Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study.
    Eur J Contracept Reprod Health Care. 2024;29:109-114.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  29. TJALMA WAA, Konno R, van Heerden J
    The deadlock on HPV vaccination in Japan is almost broken!
    Eur J Obstet Gynecol Reprod Biol. 2024;297:267-269.
    PubMed        


    Eur J Obstet Gynecol Reprod Biol X

  30. KUMAR M, Baruah U, Begum D, Barmon D, et al
    To study the survival outcomes of uncommon recurrences among patients with cervical cancer compared with loco-regional and nodal recurrences at a tertiary care center in North East India - Bridging the knowledge gap in the existing literature.
    Eur J Obstet Gynecol Reprod Biol X. 2024;22:100314.
    PubMed         Abstract available


    Eur Rev Med Pharmacol Sci

  31. LI FH, Xiang L, Ran L, Zhou S, et al
    Retraction Note: BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2024;28:3294.
    PubMed         Abstract available


    FASEB J

  32. LIU X, Xie X, Li Q, Xie X, et al
    KIF23 promotes cervical cancer progression via inhibiting NLRP3-mediated pyroptosis.
    FASEB J. 2024;38:e23685.
    PubMed         Abstract available


    Front Genet

  33. JIANG S, Lin X, Wu Q, Zheng J, et al
    Transient receptor potential channels' genes forecast cervical cancer outcomes and illuminate its impact on tumor cells.
    Front Genet. 2024;15:1391842.
    PubMed         Abstract available


    Front Med (Lausanne)

  34. DI DONATO V, Bogani G, Lagana AS, Giannini A, et al
    Editorial: Early cervical cancer: laparotomic vs minimally invasive surgery and fertility-sparing possible strategies.
    Front Med (Lausanne). 2024;11:1415558.
    PubMed        


    Front Oncol

  35. NOGUEIRA-RODRIGUES A, Cetina Perez L, Maza M
    Editorial: Cervical cancer control in Latin America and the Caribbean.
    Front Oncol. 2024;13:1226915.
    PubMed        

  36. LIU J, Dong L, Zhang X, Wu Q, et al
    Radiomics analysis for prediction of lymph node metastasis after neoadjuvant chemotherapy based on pretreatment MRI in patients with locally advanced cervical cancer.
    Front Oncol. 2024;14:1376640.
    PubMed         Abstract available

  37. CHANG L, Zhao K
    Construction and validation of an innovative prognostic nomogram for overall survival in cervical cancer patients with lung metastasis: an analysis utilizing the SEER database.
    Front Oncol. 2024;14:1397454.
    PubMed         Abstract available

  38. CHENG L, Li Z, Zheng Q, Yao Q, et al
    Correlation study of serum lipid levels and lipid metabolism-related genes in cervical cancer.
    Front Oncol. 2024;14:1384778.
    PubMed         Abstract available

  39. OHTAKA T, Ando K, Oike T, Noda SE, et al
    The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer.
    Front Oncol. 2024;14:1366777.
    PubMed         Abstract available


    Gulf J Oncolog

  40. V VN, Dharmarajan A, Jones J, Yahiya EKN, et al
    Clinical Outcomes and Dosimetric Evaluationof Interstitial Brachytherapyin Gynecological Malignancies.
    Gulf J Oncolog. 2024;1:69-74.
    PubMed         Abstract available


    Gynecol Oncol

  41. PERSSON J, Luhrs O, Geppert B, Ekdahl L, et al
    A prospective study evaluating an optimized sentinel node algorithm in early stage cervical cancer: The PROSACC-study.
    Gynecol Oncol. 2024;187:178-183.
    PubMed         Abstract available


    Gynecol Oncol Rep

  42. DAVIDSON SJ, El-Rayes D, Khalifa M, Fok CS, et al
    HPV-independent cervical cancer associated with non-reducible pelvic organ prolapse: A case report.
    Gynecol Oncol Rep. 2024;53:101408.
    PubMed         Abstract available


    Health Policy Open

  43. GABRIELLI L, Alvim Matos SM, Luisa Patrao A, Goes EF, et al
    Do social protection programmes affect the burden of breast and cervical cancer? A systematic review.
    Health Policy Open. 2024;6:100122.
    PubMed         Abstract available


    Heliyon

  44. CHEN Y, Cui R, Xiong D, Zhao Y, et al
    Cervical cancer subtype identification and model building based on lipid metabolism and post-infection microenvironment immune landscape.
    Heliyon. 2024;10:e30746.
    PubMed         Abstract available


    Hum Vaccin Immunother

  45. AFSAR S, Hossain M, Islam M, Simmonds H, et al
    Human papillomavirus and occupational exposure: The need for vaccine provision for healthcare providers.
    Hum Vaccin Immunother. 2024;20:2342622.
    PubMed         Abstract available

  46. ZHU L, Cui X, Yan Z, Tao Y, et al
    Design and evaluation of a multi-epitope DNA vaccine against HPV16.
    Hum Vaccin Immunother. 2024;20:2352908.
    PubMed         Abstract available


    Int J Womens Health

  47. WIRYANTI W, Fikri E
    Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer [Letter].
    Int J Womens Health. 2024;16:829-830.
    PubMed        


    J Cancer Educ

  48. GARCIA K, Iacob E, Dean-Smith M, Royce E, et al
    Low Levels of Lifetime Pap Test Receipt Among Vulnerable Guatemalans.
    J Cancer Educ. 2024;39:264-270.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  49. XIAO Y, Zhi Y, Cao G, Ma H, et al
    Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
    J Cancer Res Clin Oncol. 2024;150:267.
    PubMed         Abstract available


    J Cytol

  50. FERNANDES SPM, Vilarinho AS, Frutuoso A, Teixeira C, et al
    Application of CytoPath(R)Easy Vials in Cervical Cancer Screening: Self-Sampling Approach.
    J Cytol. 2024;41:67-74.
    PubMed         Abstract available


    J Gynecol Oncol

  51. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
    Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins.
    J Gynecol Oncol. 2024;35:e28.
    PubMed         Abstract available

  52. KIM H, Kim KY, Kim D, Hwang JH, et al
    Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance.
    J Gynecol Oncol. 2024;35:e26.
    PubMed         Abstract available

  53. VERIT FF, Bese T, Demirkiran F
    Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.
    J Gynecol Oncol. 2024 May 10. doi: 10.3802/jgo.2024.
    PubMed        

  54. BOSE CK, Basu N
    Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer.
    J Gynecol Oncol. 2024 May 17. doi: 10.3802/jgo.2024.
    PubMed         Abstract available


    J Mol Diagn

  55. QI M, Naranjo AR, Duque AJ, Lorey TS, et al
    Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs.
    J Mol Diagn. 2024;26:487-497.
    PubMed         Abstract available


    J Radiat Res

  56. OKONOGI N, Murakami N, Takatsu J, Iijima K, et al
    Hands-on-training tailored in response to pre-questionnaire-based survey on image-guided brachytherapy effectively reduces anxiety about its implementation.
    J Radiat Res. 2024;65:323-327.
    PubMed         Abstract available


    Mar Drugs

  57. XU S, Li Z, Xin X, An F, et al
    Curdepsidone A Induces Intrinsic Apoptosis and Inhibits Protective Autophagy via the ROS/PI3K/AKT Signaling Pathway in HeLa Cells.
    Mar Drugs. 2024;22:227.
    PubMed         Abstract available


    Mol Cell Biochem

  58. ATRI Y, Bharti H, Sahani N, Sarkar DP, et al
    CUL4A silencing attenuates cervical carcinogenesis and improves Cisplatin sensitivity.
    Mol Cell Biochem. 2024;479:1041-1058.
    PubMed         Abstract available


    Nat Commun

  59. WANG J, Yu Y, Tan Y, Wan H, et al
    Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.
    Nat Commun. 2024;15:4369.
    PubMed         Abstract available


    Oncogene

  60. PATTERSON MR, Meijers AS, Ryder EL, Wootton LM, et al
    E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
    Oncogene. 2024 May 24. doi: 10.1038/s41388-024-03067.
    PubMed         Abstract available


    PLoS One

  61. ILIKA CP, Eleje GU, Chiemeka ME, Ilika FN, et al
    Effects of speculum lubrication on cervical smears for cervical cancer screening: A double blind randomized clinical trial.
    PLoS One. 2024;19:e0292207.
    PubMed         Abstract available

  62. BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
    Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    PLoS One. 2024;19:e0301997.
    PubMed         Abstract available


    Prev Med

  63. DESAI KT, Doorbar J, de Sanjose S, Schiffman M, et al
    Response letter to "Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer".
    Prev Med. 2024;184:108005.
    PubMed        


    Radiother Oncol

  64. AI Y, Zhu X, Zhang Y, Li W, et al
    MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer.
    Radiother Oncol. 2024;197:110328.
    PubMed         Abstract available


    Rev Bras Ginecol Obstet


  65. The path to elimination: FEBRASGO 2023's targeted strategies against cervical cancer in Brazil.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgoedt2.
    PubMed        


    Rev Med Liege

  66. PLEYERS C
    [Brachytherapy : a crucial part of locally advanced cervical cancer treatment].
    Rev Med Liege. 2024;79.
    PubMed         Abstract available


    SAGE Open Med

  67. SSEDYABANE F, Niyonzima N, Nambi Najjuma J, Birungi A, et al
    Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.
    SAGE Open Med. 2024;12:20503121241252265.
    PubMed         Abstract available


    SAGE Open Med Case Rep

  68. HAIDAR A, Andour H, Essaber H, Abdallah H, et al
    Imaging of an exceptional urinoma complicating a cervical cancer and leading to death: A case report.
    SAGE Open Med Case Rep. 2024;12:2050313X241253748.
    PubMed         Abstract available


    Sci Rep

  69. LI X, Xiang F, Liu T, Chen Z, et al
    Leveraging existing 16S rRNA gene surveys to decipher microbial signatures and dysbiosis in cervical carcinogenesis.
    Sci Rep. 2024;14:11532.
    PubMed         Abstract available


    Tohoku J Exp Med

  70. ISHIBASHI M, Niikura H, Ishida M, Iwama N, et al
    Long-Term and Short-Interval Assessment of Self-Reported Urinary and Sexual Functions after Nerve-Sparing Radical Hysterectomy: A Prospective Cohort Study.
    Tohoku J Exp Med. 2024;263:1-9.
    PubMed         Abstract available


    Transl Oncol

  71. WAN F, Qiu F, Deng Y, Hu H, et al
    Knockdown of YTHDF2 initiates ERS-induced apoptosis and cancer stemness suppression by sustaining GLI2 stability in cervical cancer.
    Transl Oncol. 2024;46:101994.
    PubMed         Abstract available


    Zhonghua Yi Xue Za Zhi

  72. SHANG X, Kong LH, Xiao XP, Wan R, et al
    [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
    Zhonghua Yi Xue Za Zhi. 2024;104:1852-1859.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.